Three times as many patients treated with intravenous (IV) tenecteplase (TNK) administered up to 24 hours after symptom onset achieve major reperfusion without symptomatic intracranial hemorrhage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback